Cardiac metabolomics stands at the forefront of scientific inquiry, delving into the intricate world of small molecules governing the metabolic intricacies within the heart. This emerging discipline employs advanced analytical techniques to comprehensively explore the dynamic landscape of metabolites, unraveling the complex web of metabolic pathways in the cardiovascular system. By deciphering the nuanced changes in metabolite profiles, researchers aim to uncover the molecular underpinnings of cardiac health and disease. This profound understanding has the potential to revolutionize diagnostic approaches and therapeutic strategies, offering a unique perspective on personalized medicine in the realm of cardiovascular care. In the realm of cardiac metabolomics, scientists strive to identify distinctive metabolic signatures linked to various cardiac conditions, paving the way for tailored interventions and enhancing our ability to precisely detect, monitor, and treat cardiovascular diseases.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation